What health professionals do with the person in front of them who's at high risk already, who has cardiovascular disease, or whose overweight is contributing to their risk. It's timely, because we've got GLP-1 therapies available for the first time, which not only help people control their weight, but also have consequences in terms of reducing cardiovascular events and improving outcomes. Australia leading the world in GLP-1 guidance Prof
In a document circulated to employees, Cigna suggested those currently using the medications can choose to pay for the drugs with cash through manufacturer sites or TrumpRx
Our findings support the investigation of lower GLP-1RA dosing in HFpEF and other cardiovascular conditions, including in non-obese patients, to expand the clinical utility of these potent drugs
This is when you are getting the most powerful dose of medication
Muscle preservation, gut health, and hydration as new purchase drivers People are now paying more attention to what their food can do for their health
(Interestingly, hes found that increasing the very small amount formed in the nasal systems olfactory bulb seems to amplify the motivation to eat.) His hope is that eventually we will be able to activate very specific pathways in the brain using the drug, which would allow for more narrowly targeted pharmaceutical treatments
